BioHealth News Archive
Tick tock: Register now, 2019 Technology Showcase
June 12, 2019! Register now for the 3rd annual Technology Showcase! The 2019 Technology Showcase will again highlight technologies being developed at the NCI and…
Read More
Johns Hopkins founded and BHCR Crab Trap Winner medical research firm LifeSprout gets financing boost – Baltimore Sun
A Baltimore-based regenerative medicine firm called LifeSprout, which makes synthetic products used to restore soft tissue, has secured $6.5 million in financing. {iframe}https://www.baltimoresun.com/business/bs-bz-lifesprout-financing-20190529-story.html{/iframe}
Read More
Baltimore firm raises $110 million to bring Johns Hopkins’ cancer-detecting blood test to market – Baltimore Sun
A newly formed Baltimore company has raised $110 million to commercialize a cancer-detecting blood test, developed by Johns Hopkins researchers, that doctors would give…
Read More
QIAGEN launches first FDA-approved companion diagnostic for PIK3CA biomarkers to enhance precision medicine in breast cancer
QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the immediate launch of its therascreen® PIK3CA RGQ PCR Kit (therascreen PIK3CA Kit) after it…
Read More
With FDA Approval Of Zolgensma, Regenxbio Sets Out For First Revenue Stream – REGENXBIO Inc. (NASDAQ:RGNX) | Seeking Alpha
Regenxbio (RGNX) announced that a gene therapy developed based on its technology was approved by the FDA. This gene therapy product is known as…
Read More
NHLBI Funding & Research Opportunities and Announcements for May 3, 2019
Funding and Research Opportunities The following funding opportunity announcements from the NHLBI or other components of the National Institutes of Health, might be of interest:…
Read More
Gaithersburg’s Viela Bio strikes $220M partnership with Hansoh Pharmaceutical Group – Washington Business Journal
It's the local company's first step toward establishing an international presence after it was spun out last year from MedImmune. {iframe}https://www.bizjournals.com/washington/news/2019/05/28/gaithersburg-s-viela-bio-strikes-220m-deal-with.html{/iframe}
Read More
Rexahn Announces Move to Nasdaq – Rexahn Pharmaceuticals, Inc.
Rexahn Pharmaceuticals, Inc. (NYSE American: RNN), a clinical stage biopharmaceutical company developing innovative therapies to improve patient outcomes in cancers that are difficult to…
Read More
Incubator “Cheat Sheet” for Life Science Entrepreneurs in the BioHealth Capital Region · BioBuzz
The BioHealth Capital Region (BHCR) continues to grow rapidly with new startups and a greater number of clinical and commercial stage companies. The region…
Read More
2019 BioHealth Capital Region Forum Photos
If you need great photographer for your event, contact UZI Photography who covered the 5th Annual BioHeallth Capital Region Forum
Read More
Rockville biotech raising $7.5M for new manufacturing facility – Baltimore Business Journal
This is the first raise for the business, which has been profitable and fueled growth organically up to this point. {iframe}https://www.bizjournals.com/baltimore/news/2019/05/24/rockville-biotech-raising-7-5m-for-new.html{/iframe}
Read More
Inaugural InteGIRLS math competition draws more than 100 STEM-loving girls to Rockville | WTOP
A group of high school girls who wanted to create a local community for other young ladies interested in STEM subjects (science, technology, engineering…
Read More
Attend the Inaugural AURP BioHealth Caucus in Philadelphia on Monday, June 3rd
Meet Up with AURP at BIO in Philadelphia forAURP's BIO Health Caucus#AURPBHC2019 June 2 - 3, 2019 At AURP’s BIO Health Caucus, we will explore…
Read More
Modeling Virus Clearance: Use of a Noninfectious Surrogate of Mouse Minute Virus As a Tool for Evaluating an Anion-Exchange Chromatography Method – BioProcess InternationalBioProcess International
Viral safety is a critical focus during biopharmaceutical manufacturing (1–5). Although well-characterized mammalian cells such as the Chinese hamster ovary (CHO) line have been…
Read More
25 Up-and-Coming Gene Therapies of 2019
Data released May 9 by the Alliance for Regenerative Medicine (ARM) illustrates the growth of clinical activity where gene therapy is concerned. ARM’s Quarterly…
Read More